Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

SMFRW

Sema4 (SMFRW)

Sema4 Holdings Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SMFRW
일자시간출처헤드라인심볼기업
2023/01/0922:30GlobeNewswire Inc.Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 GuidanceNASDAQ:SMFRWSema4 Holdings Corporation
2022/12/3022:30GlobeNewswire Inc.Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:SMFRWSema4 Holdings Corporation
2022/12/0522:00GlobeNewswire Inc.New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICUNASDAQ:SMFRWSema4 Holdings Corporation
2022/11/1422:02GlobeNewswire Inc.Sema4 Reports Third Quarter 2022 Financial Results and New Strategic DirectionNASDAQ:SMFRWSema4 Holdings Corporation
2022/11/0505:05GlobeNewswire Inc.Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022NASDAQ:SMFRWSema4 Holdings Corporation
2022/10/3122:00GlobeNewswire Inc.Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained EpilepsiesNASDAQ:SMFRWSema4 Holdings Corporation
2022/10/2721:00GlobeNewswire Inc.Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill NewbornsNASDAQ:SMFRWSema4 Holdings Corporation
2022/10/2621:00GlobeNewswire Inc.Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panelsNASDAQ:SMFRWSema4 Holdings Corporation
2022/10/1321:00GlobeNewswire Inc.Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum DisordersNASDAQ:SMFRWSema4 Holdings Corporation
2022/10/0521:00GlobeNewswire Inc.Sema4|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening StudyNASDAQ:SMFRWSema4 Holdings Corporation
2022/08/2621:00GlobeNewswire Inc.Sema4 Appoints Healthcare and Diagnostics Industry Veteran Kevin Feeley as Chief Financial OfficerNASDAQ:SMFRWSema4 Holdings Corporation
2022/08/1605:05GlobeNewswire Inc.Sema4 Announces Continued Restructuring, Business Highlights, and Reports Second Quarter 2022 Financial ResultsNASDAQ:SMFRWSema4 Holdings Corporation
2022/08/1605:05GlobeNewswire Inc.Sema4 Announces Changes to its Research & Development LeadershipNASDAQ:SMFRWSema4 Holdings Corporation
2022/07/2621:00GlobeNewswire Inc.Sema4 to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022NASDAQ:SMFRWSema4 Holdings Corporation
2022/06/1505:30GlobeNewswire Inc.Sema4 Announces Chief Financial Officer Transition PlanNASDAQ:SMFRWSema4 Holdings Corporation
2022/06/0121:30GlobeNewswire Inc.Avera Health and Sema4 Announce Data-driven Study to Advance Cancer Treatment Across the Avera Service AreaNASDAQ:SMFRWSema4 Holdings Corporation
2022/05/2621:00GlobeNewswire Inc.Sema4 to Participate at Two Investor Conferences in June 2022NASDAQ:SMFRWSema4 Holdings Corporation
2022/05/1305:05GlobeNewswire Inc.Sema4 Reports First Quarter 2022 Financial Results and Business HighlightsNASDAQ:SMFRWSema4 Holdings Corporation
2022/05/0505:05GlobeNewswire Inc.Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SMFRWSema4 Holdings Corporation
2022/05/0220:45GlobeNewswire Inc.Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data PlatformsNASDAQ:SMFRWSema4 Holdings Corporation
2022/04/2705:05GlobeNewswire Inc.Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022NASDAQ:SMFRWSema4 Holdings Corporation
2022/04/0621:00GlobeNewswire Inc.Sema4 Achieves HITRUST CSF CertificationNASDAQ:SMFRWSema4 Holdings Corporation
2022/04/0521:00GlobeNewswire Inc.Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer TherapyNASDAQ:SMFRWSema4 Holdings Corporation
2022/03/1621:00GlobeNewswire Inc.Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved CommunitiesNASDAQ:SMFRWSema4 Holdings Corporation
2022/03/1505:05GlobeNewswire Inc.Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business HighlightsNASDAQ:SMFRWSema4 Holdings Corporation
2022/03/0822:00GlobeNewswire Inc.Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022NASDAQ:SMFRWSema4 Holdings Corporation
2022/02/2306:05GlobeNewswire Inc.Sema4 to Report Fourth Quarter and Full Year 2021 Financial Results and Participate in Investor Conferences in March 2022NASDAQ:SMFRWSema4 Holdings Corporation
2022/02/2222:00GlobeNewswire Inc.Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision MedicineNASDAQ:SMFRWSema4 Holdings Corporation
2022/02/0406:05GlobeNewswire Inc.Sema4 to Participate at Two Upcoming Investor Conferences in FebruaryNASDAQ:SMFRWSema4 Holdings Corporation
2022/02/0121:30GlobeNewswire Inc.Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement CapabilitiesNASDAQ:SMFRWSema4 Holdings Corporation
 검색 관련기사 보기:NASDAQ:SMFRW